The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers

PURPOSE: Sodium-glucose co-transporter-2 inhibitor (SGLT-2i) administration is associated with some concerns in regard to the increased risk of genital and urinary tract infections (UTI) in kidney transplant recipients (KTR). In this study, we present the results of SGLT-2i use in KTR, including the...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, Mehmet Emin, Özler, Tuba Elif, Merhametsiz, Özgür, Sözener, Ulaş, Uyar, Murathan, Ercan, Zafer, Bardak Demir, Simge, Sezer, Siren, Türkmen Sarıyıldız, Gülçin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248967/
https://www.ncbi.nlm.nih.gov/pubmed/37289399
http://dx.doi.org/10.1007/s11255-023-03645-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248967/
https://www.ncbi.nlm.nih.gov/pubmed/37289399
http://dx.doi.org/10.1007/s11255-023-03645-7

Ejemplares similares